Beyond Creams: How Digital Tools Can Personalize Acne Care and Improve Adherence

As the U.S. acne market is projected to expand significantly through 2033, the opportunity for digital tools to improve how people choose and stick with acne treatments is growing too. According to recent market forecasts, brands from Proactiv to La Roche-Posay will compete in a larger, more technologically enabled space — and that creates new choices for patients, especially adults with persistent acne who need tailored care and better support to complete treatment plans.¹

Why this matters: adult acne, rising demand, and unmet needs

Adult acne (often defined as acne persisting past age 25) affects a meaningful portion of the population and can be more inflammatory, scarring, and psychologically burdensome than adolescent acne. Yet adults frequently delay care, try multiple over-the-counter (OTC) products, or abandon prescriptions because of side effects, cost, or confusion about correct use. With the acne market growth projected through 2026–2033, there's an opening for teledermatology, AI skin-assessment apps, and digital therapeutics to help patients choose the right OTC vs prescription pathway and stay on treatment.

How digital tools change the decision: OTC vs prescription

Choosing between OTC and prescription options isn't only about severity; it includes skin type, previous treatments, side effect risk, and lifestyle. Digital tools can make that decision evidence-based and patient-centered.

Teledermatology: rapid clinical input

Teledermatology platforms allow clinicians to:

• Assess photos or live video and classify acne severity (mild, moderate, severe).
• Recommend OTC regimens (benzoyl peroxide, salicylic acid, topical retinoids available OTC in some regions) or prescribe topical/oral therapies.
• Monitor response remotely and step up or change therapy without unnecessary clinic visits.

Typical workflow: patient uploads images via a secure portal → clinician reviews severity and history → treatment recommendation issued with follow-up plan. This can reduce time-to-treatment and clarify whether a person should try OTC first or jump to prescription care.

AI skin analysis: triage and personalization at scale

AI-powered apps can analyze lesion types, count papules/pustules, flag scarring risk, and score severity. When combined with patient-reported history (prior treatments, sensitivities, pregnancy status), AI outputs can:

• Provide an evidence-based triage score (try OTC vs need dermatologist).
• Suggest product classes and routines tailored to skin type and lifestyle.
• Track progress objectively with image-based metrics, improving adherence by showing measurable change.

Important caveats: AI is a decision-support tool, not a replacement for clinical judgment. Patients should use validated apps and, when in doubt, connect to teledermatology. For more on benefits and risks of AI in telemedicine, see our primer The Rise of AI in Telemedicine.

Practical pathway: deciding OTC vs prescription (a step-by-step guide)

Use this brief decision flow when starting care or re-evaluating ineffective regimens.

1. Self-check and document symptoms: duration, lesion type, pain, scarring, and prior treatments.
2. Use an AI skin-assessment app or teletriage service to get an initial severity score and red flags (e.g., cystic lesions, rapid progression).
3. If scored mild and no scarring: start an evidence-based OTC regimen for 8–12 weeks with measurement plan (photo every 2 weeks).
4. If scored moderate-to-severe, scarring risk, or treatment failure after OTC trial: schedule teledermatology or in-person consult for potential prescription (topical retinoid, topical antibiotics, systemic therapy).
5. Follow-up: schedule digital check-ins at 2, 6, and 12 weeks; escalate care earlier for worsening or intolerable side effects.

Digital strategies to improve treatment adherence

Nonadherence is common in acne care because visible results take weeks, side effects are immediate, and regimens can be complex. Digital tools can apply behavioral science to bridge that gap.

Automated adherence nudges

Automated nudges are short, timed prompts that support habit formation and reduce friction. Effective nudges include:

• Morning/evening reminders synced to phone calendars and smartwatches.
• Contextual nudges: "Apply topical retinoid after brushing teeth" to tie the behavior to an existing routine.
• Refill reminders based on prescription duration and supply tracking.

Digital therapeutics and engagement features

Regulated digital therapeutics (DTx) combine software interventions with clinical oversight. For acne care, DTx can include:

• Structured education modules on correct application, side-effect management, and sun protection.
• Progress visualization: before/after photos and objective lesion counts to show early wins.
• Secure messaging with clinicians to troubleshoot irritation before the patient abandons treatment.

These features increase persistence by making the treatment journey feel supported rather than solitary.

Behavioral design tips clinicians can deploy

• Set a shared, measurable goal (e.g., 50% lesion reduction in 12 weeks) at the first visit.
• Prescribe simple regimens where possible; fewer daily steps increase adherence.
• Use microlearning (1–2 minute videos) to teach application and side-effect mitigation.

Example nudge scripts and schedules

Patients and platforms can use these templates to craft reminders that feel personalized:

• Initial onboarding message: "Welcome! Your 12-week acne plan starts today. Post a photo in the app every 2 weeks so we can track progress. Tap here for tips on applying topical meds."
• Daily reminder: "Good morning — apply your acne medication after your morning cleanser. Small habits, big results."
• Reassurance nudge (week 2): "Irritation is common in the first 2–3 weeks. If it's severe, message your clinician through the app. Don't stop abruptly."

Integrations that matter

For digital tools to be effective they should plug into existing health ecosystems:

• EHR and telemedicine platforms for continuity of care.
• Pharmacy integration for auto-refill and price transparency.
• Measurement tools for clinicians: lesion counts, photographic timelines, and adherence analytics.

Clinicians and product teams must consider the trade-offs between convenience and data security. For a deeper look at trust and adoption in AI solutions, see Building Trust in AI-Powered Health Solutions and how AI impacts the human touch in care The Future of Healthcare: AI vs. Human Touch.

When to escalate to in-person care

Digital tools can manage many cases, but escalation is essential when:

• There is rapid worsening, nodulocystic lesions, or severe pain.
• There are signs of scarring or infection.
• Pregnancy, breastfeeding, or complex medical history affects medication safety.

Teledermatology can triage and prioritize urgent in-person appointments to avoid delays in care.

Privacy, validation, and equitable access

Patients should choose tools that are transparent about data use, HIPAA-compliant (or regional equivalent), and validated in peer-reviewed studies when possible. Equity matters: apps should work across a range of skin tones and devices. Developers and clinicians must test algorithms across diverse populations and publish results; for implementation risks and hardware considerations, read Evaluating AI Hardware for Telemedicine.

Actionable checklist for patients

1. Start: take clear photos in natural light and answer a short history questionnaire in an app or teletriage service.
2. Decide: follow the AI/telederm recommendation—try OTC for mild cases for 8–12 weeks; seek prescription for moderate/severe or scarring risk.
3. Adhere: enable two daily reminders, set photo checkpoints every 2 weeks, and keep a symptom log.
4. Communicate: use secure messaging for side effects instead of stopping medication abruptly.
5. Review: schedule a telederm follow-up at week 6 and 12 to adjust therapy and prevent long-term scarring.

Conclusion: empowerment through smart digital design

The growing acne market means more products and more channels for care — but it also creates complexity. Teledermatology, AI skin-assessment apps, and digital therapeutics offer a path to simplify decisions, personalize treatment, and keep patients engaged. When designed and deployed responsibly, these tools empower adults with persistent acne to choose the right OTC vs prescription pathway and, crucially, stick with the treatment long enough to see results.

For practical implementation and clinician-facing strategies, consider our guide on how AI-enhanced telemedicine can transform chronic disease management: How AI-Enhanced Telemedicine Will Transform Chronic Disease Management.